Department of Cancer Pharmacology & Pharmacogenomics, Levine Cancer Institute, Atrium Health, Charlotte, NC 28204, USA.
Center for Applied Genomics & Precision Medicine, Duke University & Duke Health System, Durham, NC 27710, USA.
Pharmacogenomics. 2021 Jan;22(2):73-80. doi: 10.2217/pgs-2020-0156. Epub 2021 Jan 15.
The North Carolina Precision Health Collaborative is an interdisciplinary, public-private consortium of precision health experts who strategically align statewide resources and strengths to elevate precision health in the state and beyond. Pharmacogenomics (PGx) is a key area of focus for the North Carolina Precision Health Collaborative. Experts from Atrium Health's Levine Cancer Institute, Duke University/Duke Health System, Mission Health and the University of North Carolina (UNC) at Chapel Hill/UNC Health System have collaborated since 2017 to implement strategic PGx initiatives, including basic sciences research, translational research and clinical implementation of germline testing into practice and policy. This institutional profile highlights major PGx programs and initiatives across these organizations and how the collaborative is working together to advance PGx science and implementation.
北卡罗来纳精准健康合作组织是一个跨学科的公私合作伙伴关系，由精准健康专家组成，旨在战略性地整合全州资源和优势，提升该州乃至全美精准健康水平。药物基因组学（PGx）是北卡罗来纳精准健康合作组织的重点关注领域之一。自 2017 年以来，来自莱文癌症研究所、杜克大学/杜克健康系统、使命健康和北卡罗来纳大学教堂山分校/北卡罗来纳大学卫生系统的专家们合作实施了战略 PGx 计划，包括基础科学研究、转化研究以及将种系测试临床实施和政策结合。本机构简介重点介绍了这些组织的主要 PGx 计划和举措，以及合作组织如何共同努力推进 PGx 科学和实施。
